Table 3.
Resource Effective Strategies | Level of Evidence* | References |
---|---|---|
Tobacco prevention and control policies (WHO MPOWER) | A | 58-60 |
Improving price, availability and marketing of healthy foods | C | 61-65 |
Simplified CVD-risk screening and management algorithms | B | 66 |
Availability of combination therapy for CVD | A | 12, 67-71 |
Task-sharing with NPHWs and treatment supporters | B | 72-78 |
Level-A body of evidence = multiple populations have been evaluated, or data are derived from multiple randomized clinical trials or meta-analyses. A level-B body of evidence = limited populations have been evaluated, or data are derived from a single randomized trial or nonrandomized trial. A level-C body of evidence = very limited populations have been evaluated or that only the consensus opinions of experts, case studies, or standards of care support the recommendation.
WHO=World Health organization, CVD=cardiovascular disease, NPHWs=non-physician health workers